Men B: Lack of coverage or vaccine failure?

Christopher D. Bayliss; Julie A. Morrissey; Ray Borrow

doi:10.1016/S0140-6736(16)00218-X

Men B: Lack of coverage or vaccine failure?

Christopher D. Bayliss^*
, Julie A. Morrissey
, Ray Borrow

^*Corresponding author for this work

Manchester Lab Vaccine Evaluation

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	531-532
Number of pages	2
Journal	The Lancet
Volume	387
Issue number	10018
DOIs	https://doi.org/10.1016/S0140-6736(16)00218-X
Publication status	Published - 6 Feb 2016

Bibliographical note

Funding Information:
CDB, JAM, and RB are in receipt of funding from the Meningitis Research Foundation for a project entitled “Determining the molecular basis of vaccine failure” by Bexsero. RB has conducted clinical trials of capsular group B meningococcal vaccines on behalf of Public Health England funded by Novartis Vaccines and Pfizer but has no pecuniary or other interests with any vaccine manufacturer. CDB and JAM declare no competing interests.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0140-6736(16)00218-X

Cite this

@article{aae96c386c544e5abe957c8dc444362b,

title = "Men B: Lack of coverage or vaccine failure?",

author = "Bayliss, \{Christopher D.\} and Morrissey, \{Julie A.\} and Ray Borrow",

note = "Funding Information: CDB, JAM, and RB are in receipt of funding from the Meningitis Research Foundation for a project entitled {\textquotedblleft}Determining the molecular basis of vaccine failure{\textquotedblright} by Bexsero. RB has conducted clinical trials of capsular group B meningococcal vaccines on behalf of Public Health England funded by Novartis Vaccines and Pfizer but has no pecuniary or other interests with any vaccine manufacturer. CDB and JAM declare no competing interests. ",

year = "2016",

month = feb,

day = "6",

doi = "10.1016/S0140-6736(16)00218-X",

language = "English",

volume = "387",

pages = "531--532",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10018",

}

TY - JOUR

T1 - Men B

T2 - Lack of coverage or vaccine failure?

AU - Bayliss, Christopher D.

AU - Morrissey, Julie A.

AU - Borrow, Ray

N1 - Funding Information: CDB, JAM, and RB are in receipt of funding from the Meningitis Research Foundation for a project entitled “Determining the molecular basis of vaccine failure” by Bexsero. RB has conducted clinical trials of capsular group B meningococcal vaccines on behalf of Public Health England funded by Novartis Vaccines and Pfizer but has no pecuniary or other interests with any vaccine manufacturer. CDB and JAM declare no competing interests.

PY - 2016/2/6

Y1 - 2016/2/6

UR - https://www.scopus.com/pages/publications/84959483222

U2 - 10.1016/S0140-6736(16)00218-X

DO - 10.1016/S0140-6736(16)00218-X

M3 - Letter

C2 - 26867439

AN - SCOPUS:84959483222

SN - 0140-6736

VL - 387

SP - 531

EP - 532

JO - The Lancet

JF - The Lancet

IS - 10018

ER -

Men B: Lack of coverage or vaccine failure?

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this